@article{couillard_predicting_2022,
	title = {Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype {Oxford} {Asthma} {Attack} {Risk} {Scale} ({ORACLE})},
	volume = {8},
	issn = {2312-0541},
	url = {http://openres.ersjournals.com/lookup/doi/10.1183/23120541.00570-2021},
	doi = {10.1183/23120541.00570-2021},
	language = {en},
	number = {1},
	urldate = {2024-05-30},
	journal = {ERJ Open Research},
	author = {Couillard, Simon and Do, William Il Hoon and Beasley, Richard and Hinks, Timothy S.C. and Pavord, Ian D.},
	month = jan,
	year = {2022},
	pages = {00570--2021},
}

{"_id":"ni7S8ZvJaGKMydwCx","bibbaseid":"couillard-do-beasley-hinks-pavord-predictingthebenefitsoftype2targetedantiinflammatorytreatmentwiththeprototypeoxfordasthmaattackriskscaleoracle-2022","author_short":["Couillard, S.","Do, W. I. H.","Beasley, R.","Hinks, T. S.","Pavord, I. D."],"bibdata":{"bibtype":"article","type":"article","title":"Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype Oxford Asthma Attack Risk Scale (ORACLE)","volume":"8","issn":"2312-0541","url":"http://openres.ersjournals.com/lookup/doi/10.1183/23120541.00570-2021","doi":"10.1183/23120541.00570-2021","language":"en","number":"1","urldate":"2024-05-30","journal":"ERJ Open Research","author":[{"propositions":[],"lastnames":["Couillard"],"firstnames":["Simon"],"suffixes":[]},{"propositions":[],"lastnames":["Do"],"firstnames":["William","Il","Hoon"],"suffixes":[]},{"propositions":[],"lastnames":["Beasley"],"firstnames":["Richard"],"suffixes":[]},{"propositions":[],"lastnames":["Hinks"],"firstnames":["Timothy","S.C."],"suffixes":[]},{"propositions":[],"lastnames":["Pavord"],"firstnames":["Ian","D."],"suffixes":[]}],"month":"January","year":"2022","pages":"00570–2021","bibtex":"@article{couillard_predicting_2022,\n\ttitle = {Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype {Oxford} {Asthma} {Attack} {Risk} {Scale} ({ORACLE})},\n\tvolume = {8},\n\tissn = {2312-0541},\n\turl = {http://openres.ersjournals.com/lookup/doi/10.1183/23120541.00570-2021},\n\tdoi = {10.1183/23120541.00570-2021},\n\tlanguage = {en},\n\tnumber = {1},\n\turldate = {2024-05-30},\n\tjournal = {ERJ Open Research},\n\tauthor = {Couillard, Simon and Do, William Il Hoon and Beasley, Richard and Hinks, Timothy S.C. and Pavord, Ian D.},\n\tmonth = jan,\n\tyear = {2022},\n\tpages = {00570--2021},\n}\n\n","author_short":["Couillard, S.","Do, W. I. H.","Beasley, R.","Hinks, T. S.","Pavord, I. D."],"key":"couillard_predicting_2022","id":"couillard_predicting_2022","bibbaseid":"couillard-do-beasley-hinks-pavord-predictingthebenefitsoftype2targetedantiinflammatorytreatmentwiththeprototypeoxfordasthmaattackriskscaleoracle-2022","role":"author","urls":{"Paper":"http://openres.ersjournals.com/lookup/doi/10.1183/23120541.00570-2021"},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://api.zotero.org/users/6607533/collections/VKGURBGN/items?key=hSjrOPQRRHHWY81SKs6CEz45&format=bibtex&limit=100","dataSources":["zpWcq5jS35za3AmLx","upP78A3qvEd6tbHFm"],"keywords":[],"search_terms":["predicting","benefits","type","targeted","anti","inflammatory","treatment","prototype","oxford","asthma","attack","risk","scale","oracle","couillard","do","beasley","hinks","pavord"],"title":"Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype Oxford Asthma Attack Risk Scale (ORACLE)","year":2022}